- Report
- November 2023
- 175 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- January 2024
- 150 Pages
Global
From €4654EUR$4,850USD£4,008GBP
- Report
- May 2024
- 184 Pages
Global
From €3237EUR$3,374USD£2,788GBP
€3597EUR$3,749USD£3,098GBP
- Report
- May 2024
- 199 Pages
Global
From €3237EUR$3,374USD£2,788GBP
€3597EUR$3,749USD£3,098GBP
- Report
- November 2023
- 144 Pages
Global
From €2398EUR$2,499USD£2,065GBP
- Report
- May 2024
- 192 Pages
Global
From €4749EUR$4,950USD£4,091GBP
- Report
- May 2024
- 194 Pages
Global
From €4749EUR$4,950USD£4,091GBP
- Report
- May 2024
- 271 Pages
Global
From €5229EUR$5,450USD£4,504GBP
- Report
- May 2024
- 258 Pages
Global
From €5229EUR$5,450USD£4,504GBP
- Report
- May 2024
- 194 Pages
Global
From €4749EUR$4,950USD£4,091GBP
- Report
- May 2024
- 196 Pages
Global
From €4749EUR$4,950USD£4,091GBP
- Report
- May 2024
- 93 Pages
Global
From €5373EUR$5,600USD£4,628GBP
- Report
- May 2024
- 194 Pages
Global
From €4749EUR$4,950USD£4,091GBP
- Report
- October 2023
- 113 Pages
Global
From €5709EUR$5,950USD£4,917GBP
- Report
- January 2024
- 143 Pages
Global
From €3741EUR$3,899USD£3,222GBP
- Report
- January 2024
- 175 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- November 2023
- 250 Pages
Global
From €4797EUR$5,000USD£4,132GBP
- Report
- May 2024
- 402 Pages
Global
From €4749EUR$4,950USD£4,091GBP
- Report
- January 2024
- 190 Pages
Global
From €4701EUR$4,900USD£4,049GBP
- Report
- November 2023
- 181 Pages
Global
From €4701EUR$4,900USD£4,049GBP
The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them.
Some of the major players in the Urological Disorders Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less Read more